Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00255931 · ClinicalTrials.gov registry record · Phase 2
Impact of a Psychological Biofeedback-Relaxation Intervention on Clinical, Physical and Psychological Outcomes in Patients With Heart Failure
A Phase 2 study of Heart Failure, sponsored by University of Kentucky.
- Completed
- Registry status
- Phase 2
- Development phase
- 380
- Enrollment target
- 1
- Study location
NCT00255931 is a Phase 2 study of Heart Failure that has completed, run by University of Kentucky. The registered enrollment target is 380 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00255931, a Phase 2 study of Heart Failure, has completed, sponsored by University of Kentucky.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 380 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effect of biofeedback-relaxation combined with cognitive behavioral therapy on clinical, physical and psychological outcomes in patients with heart failure.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL Attention Placebo
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2004-07 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00255931
The ClinicalTrials.gov registry entry for NCT00255931 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 380 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (81% lower). The listed sponsor is University of Kentucky, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT00255931 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT00255931 about?
NCT00255931 is a clinical study titled "Impact of a Psychological Biofeedback-Relaxation Intervention on Clinical, Physical and Psychological Outcomes in Patients With Heart Failure". The purpose of this study is to determine the effect of biofeedback-relaxation combined with cognitive behavioral therapy on clinical, physical and psychological outcomes in patients with heart failure.
What is the current status of trial NCT00255931?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 380 participants. The study started on 2004-07. Estimated completion is 2010-05.
What conditions does trial NCT00255931 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT00255931?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Attention Placebo (BEHAVIORAL).
Who is sponsoring clinical trial NCT00255931?
This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00255931 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
RECRUITING · Phase 2
-
Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial
RECRUITING · Phase 2
-
Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
RECRUITING · Phase 2
-
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
RECRUITING · Phase 2
-
Metformin for Pulmonary Hypertension HFpEF
RECRUITING · Phase 2
-
The Inorganic Nitrate and eXercise Performance in Heart Failure (iNIX-HF)
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.